Alnylam Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ALNY for the last quarter is 439.72 M USD, and it's 41.41% lower compared to the previous quarter. The net income of Q4 23 is -137.87 M USD.